Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02121977 · ClinicalTrials.gov registry record · Phase 4
Study of the Elevate Anterior and Apical Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse
A Phase 4 study, sponsored by ASTORA Women's Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 285
- Enrollment target
NCT02121977 is a Phase 4 study that was terminated before completion, run by ASTORA Women's Health. The registered enrollment target is 285 participants.
The verdict
NCT02121977, a Phase 4 study, was terminated before completion, sponsored by ASTORA Women's Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 285 participants
- Enrollment target
Study Summary
The aim of this study is to further evaluate the safety and efficacy of the Elevate® Anterior and Apical Prolapse Repair System for repair of anterior/apical pelvic organ prolapse in a controlled, post-market cohort study.
Interventions
- PROCEDURE Native Tissue Repair for pelvic organ prolapse
- DEVICE Elevate Anterior and Apical
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2014-04 |
| Est. Completion | 2019-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02121977
The ClinicalTrials.gov registry entry for NCT02121977 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 285 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ASTORA Women's Health, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Native Tissue Repair for pelvic organ prolapse is the first listed.
NCT02121977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02121977 about?
NCT02121977 is a clinical study titled "Study of the Elevate Anterior and Apical Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse". The aim of this study is to further evaluate the safety and efficacy of the Elevate® Anterior and Apical Prolapse Repair System for repair of anterior/apical pelvic organ prolapse in a controlled, post-market cohort study.
What is the current status of trial NCT02121977?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 285 participants. The study started on 2014-04. Estimated completion is 2019-04.
What interventions are being tested in trial NCT02121977?
The interventions under investigation include: Native Tissue Repair for pelvic organ prolapse (PROCEDURE), Elevate Anterior and Apical (DEVICE).
Who is sponsoring clinical trial NCT02121977?
This trial is sponsored by ASTORA Women's Health, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.